ProQR Therapeutics NV (NASDAQ:PRQR)

Delayed Data
As of Dec 01
 +0.18 / +11.61%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 4.07, with a high estimate of 6.11 and a low estimate of 1.84. The median estimate represents a +135.50% increase from the last price of 1.73.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in ProQR Therapeutics NV. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 129.85%
Growthannually 67.17%


Growthquarterly 1,109.55%
Growthannually 402.08%
Key to the earnings and sales forecast charts.